• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Estimating time since influenza virus exposure using single-cell proteomic data

tetano

Editor, Senior Moderator
Front Immunol


. 2026 Mar 19:17:1787198.
doi: 10.3389/fimmu.2026.1787198. eCollection 2026.
Estimating time since influenza virus exposure using single-cell proteomic data

Klodiana Rizzo Nervo[SUP] #[/SUP][SUP] 1 [/SUP], Neda Hajiakhoond Bidoki[SUP] #[/SUP][SUP] 2 [/SUP], Han Chen[SUP] 3 [/SUP], Zainab Rahil[SUP] 3 [/SUP], Zach Bjornson[SUP] 3 [/SUP], Kenneth Kim[SUP] 4 [/SUP], Bonnie Bock[SUP] 5 [/SUP], Melton Affrime[SUP] 5 [/SUP], Logan Bauerle[SUP] 1 [/SUP], Pham Bao Tran Huynh[SUP] 1 [/SUP], David Liebowitz[SUP] 6 [/SUP], Sean Tucker[SUP] 6 [/SUP], Pier Federico Gherardini[SUP] 7 [/SUP], Garry P Nolan[SUP] 8 [/SUP], Nima Aghaeepour[SUP] 2 [/SUP], David R McIlwain[SUP] 1 [/SUP]


Affiliations
Abstract

Introduction: Determining when the onset of a respiratory infection occurred is important for effective clinical management and can aid in mapping transmission events. However, current diagnostic assays report only pathogen detection status and do not provide any information about the timing of infection, in part because of the lack of biomarkers that inform time since exposure.
Methods: To address this gap, we developed immune-based predictive models of infection timing and shedding status using data from a controlled human challenge with influenza A/California/2009 (H1N1), in which major immune cell subsets were longitudinally profiled across multiple time points before and after viral challenge using 42-marker mass cytometry panels. Random forest machine learning models were trained to address two predictive objectives: (1) distinguishing virus shedders from non-shedders and (2) estimating days post-infection challenge (DPC) from immune profiles. Model performance was evaluated within the primary challenge cohort and independently validated using data from a separate controlled human influenza challenge study using the same virus.
Results: Our analysis revealed that single-cell immune population dynamics alone encode a robust and reproducible temporal structure following influenza infection, enabling accurate estimation of virus exposure timing.
Discussion: These findings provide foundational insight into host immune responses during influenza infection and represent an early step toward a future class of immune-based diagnostics that could extend beyond pathogen detection to inform infection timing and the duration of periods associated with contagiousness.

Keywords: controlled human virus challenge; influenza A (H1N1); machine learning; mass cytometry (CyTOF); random forest models.

 
Back
Top